News
New effective drug for Cushing's syndrome
15.10.2020

The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.

The World Health Organization expects to receive at least 2 billion doses of COVID-19 vaccines next year
08.10.2020

The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.

GALAPAGOS and GILEAD have demonstrated victory over scleroderma
29.09.2020

Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.

VIR Biotechnology has demonstrated a new effective drug for hepatitis B prevention
25.09.2020

Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.

Orphan drug status has been assigned to new glioblastoma drug
22.09.2020

The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.

Tumor hypoxia - a new method for fighting cancer
18.09.2020

A new class of drugs such as HIF-2α inhibitors is considered as an addition to standard cancer immunotherapy.

Development of a new generation of immunomodulators
15.09.2020

Chinese scientists are actively engaged in the development of improved immunomodulators.

Scientists have revealed plastic particles in human bodies
11.09.2020

Studies have shown that, on average, people eat about 5 grams of plastic every week.

New genome editing technology
08.09.2020

A new control dyslipidemia method has been proposed instead of appropriate statins and lipid-lowering drugs.

Scientists have developed a new rabies vaccine
03.09.2020

Chinese scientists have developed a unique vaccine that is safe and has low adverse reactions.